Home/Filings/4/0001104659-24-009686
4//SEC Filing

Austwick Michael 4

Accession 0001104659-24-009686

CIK 0001657312other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 6:07 AM ET

Size

5.9 KB

Accession

0001104659-24-009686

Insider Transaction Report

Form 4
Period: 2024-02-01
Transactions
  • Award

    Share Options (Right to Buy)

    2024-02-01+144,000144,000 total
    Exercise: $2.29Exp: 2034-01-31Ordinary Shares (144,000 underlying)
Footnotes (2)
  • [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]The option vests and becomes exercisable as to one-third of the underlying options on February 1, 2025 and the remainder in eight equal quarterly installments thereafter.

Issuer

Verona Pharma plc

CIK 0001657312

Entity typeother

Related Parties

1
  • filerCIK 0002009903

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:07 AM ET
Size
5.9 KB